Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer

Cancer Letters

Volumn 251, Issue 2, 2007, Pages 228-236

  Götze, Tobias ^a,b   Röcken, Christoph ^c   Röhl, Friedrich W ^b   Wex, Thomas ^b   Hoffmann, Juliane ^b   Westphal, Sabine ^b   Malfertheiner, Peter ^b   Ebert, Matthias P A ^a   Dierkes, Jutta ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Folate; Gastric cancer; Genetic polymorphisms; MTHFR; Reduced folate carrier

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GAMMA GLUTAMYL HYDROLASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER;

AGED; CARBOXYPEPTIDASES; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; VITAMIN B 12;

EID: 34247599285     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.11.021     Document Type: Article

References (32)

1. B.W. Steward, WHO: World Cancer Report 2003, IARC Press, Lyon, 2004.
2. Fuchs C.S., and Mayer R. Gastric carcinoma. N. Engl. J. Med. 333 (2004) 32-41
3. Powers H.J. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J. Nutr. 135 Suppl.12 (2005) 2960-2966
4. Zhu S., Mason J., Shi Y., Hu Y., Li R., Wahg M., Zhou Y., Jin G., Xie Y., Wu G., Xia D., Qian Z., et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin. Med. J. 116 (2003) 15-19
5. Rossi E., Hung J., Beilby J.P., Knuiman M.W., Divitini M.L., and Bartholomew H. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann. Epidemiol. 16 (2006) 206-212
6. Zhang S.M., Moore S.C., Lin J., Cook N.R., Manson J.E., Lee I.M., and Buring J.E. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am. J. Epidemiol. 163 (2006) 108-115
7. Larsson S.C., Giovannucci E., and Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 740-743
8. Sanjoaquin M.A., Allen N., Couto E., Roddam A.W., and Key T.J. Folate intake and colorectal cancer risk: a meta-analytical approach. Int. J. Cancer. 113 (2005) 825-828
9. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
10. Selhub J., and Miller J.W. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 55 (1992) 131-138
11. Shane B. Folate metabolism. In: Picciano M.F., Stokstad E.L.R., and Gregory III J.F. (Eds). Folic Acid in Health and Disease (1990), Wiley-Liss, New York 65-78
12. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., and Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
13. Russo G.T., Friso S., Jacques P.F., Rogers G., Cucinotta D., Wilson P.W., Ordovas J.M., Rosenberg I.H., and Selhub J. Framingham Offspring Study Cohort. Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study Cohort. J. Nutr. 133 (2003) 3416-3421
14. Dierkes J., Jeckel A., Ambrosch A., Westphal S., Luley C., and Boeing H. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study. Metabolism 50 (2001) 640-645
15. Bagley P.J., and Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc. Natl. Acad. Sci. USA 95 (1998) 13217-13220
16. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., and Schouten E.G. MTHFR Studies Collaboration Group, MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 (1998) 2023-2031
17. Sharp L., and Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am. J. Epidemiol. 159 (2004) 423-443
18. Halsted C. Intestinal absorption of dietary folates. In: Picciano M.F., Stokstad E.L.R., and Gregory III J.F. (Eds). Folic Acid in Health and Disease (1990), Wiley-Liss, New York 23-45
19. Devlin A.M., Ling E.H., Peerson J.M., Fernando S., Clarke R., Smith A.D., and Halsted C.H. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum. Mol. Gen. 19 (2000) 2837-2844
20. Sierra E.E., and Goldman I.D. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin. Oncol. 26 2 Suppl. 6 (1999) 11-23
21. Chango A., Emery-Fillon N., de Courcy G.P., Lambert D., Pfister M., Rosenblatt D.S., and Nicolas J.P. A polymorphism (80G→A) in the Reduced Folate Carrier Gene and Its Associations with Folate Status and Homocysteinemia. Mol. Genet. Metab. 70 (2000) 310-315
22. Whetstine J.R., Gifford A.J., Witt T., Liu X.Y., Flatley R.M., Norris M., Haber M., Taub J.W., Ravindranath Y., and Matherly L.H. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin. Cancer Res. 7 (2001) 3416-3422
23. Drogan D., Klipstein-Grobusch K., Wans S., Luley C., Boeing H., and Dierkes J. Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Br. J. Nutr. 92 (2004) 489-496
24. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., and Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57 (1997) 1098-1102
25. Shen H., Xu Y., Zheng Y., Qian Y., Yu R., Qin Y., Wang X., Spitz M.R., and Wei Q. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int. J. Cancer 95 (2001) 332-336
26. Shen H., Newmann A.S., Hu Z., Zhang Z., Xu Y., Wang L., Hu X., Guo J., Wang X., and Wei Q. Methylenetetrahydrofolatereductaspolymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol. Rep. 13 (2005) 355-360
27. Graziano F., Kawakami K., Ruzzo A., Watanabe G., Santini D., Pizzagalli F., Bisonni R., Mari D., Floriani I., Catalano V., Silva R., Tonini G., et al. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int. J. Cancer 118 (2006) 628-632
28. Stolzenberg-Solomon R.Z., Qiao Y.L., Abnet C.C., Ratnasinghe D.L., Dawsey S.M., Dong Z.W., Taylor P.R., and Mark S.D. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 1222-1226
29. Vargas-Martinez C., Ordovas J.M., Wilson P.W., and Selhub J. The glutamate carboxypeptidase gene II (C>T) polymorphism does not affect folate status in the Framingham Offspring Cohort. J. Nutr. 132 (2002) 1176-1179
30. Melse-Boonstra A., Lievers K.J., Blom H.J., and Verhoef P. Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene. Am. J. Clin. Nutr. 80 (2004) 700-704
31. Ulrich C.M., Curtin K., Potter J.D., Bigler J., Caan B., and Slattery M.L. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2509-2516
32. Hamilton R., and Aaltonen L.A. Pathology and Genetics of Tumours of the Digestive System (2000), IARC Press, Lyon